-
Dementia Associated With Alzheimer’S Disease Clinical Trials And Studies 2025: EMA, PDMA, FDA Approvals, Mechanism Of Action, ROA, NDA, IND, And Companies
27 Mar 2025 01:06 GMT
… outside the brain. Currently, the drug is in Phase III stage of its clinical trial for the treatment of Dementia Associated With Alzheimer';s Disease.
Simufilam: Cassava …
-
Dimebon drug may be used in treatment for Huntington disease
09 Aug 2020 00:50 GMT
… early stage clinical trial of the tentative drug, dimebon (latrepirdine) … appear to be no treatments that may effectually change … and functional results in Alzheimer’s disease. Study authors … pharmaceutical company which funded the study. Apparently, the drug …
-
Alzheimers Therapeutic Global Market Report 2022: Featuring Pfizer, Novartis, AstraZeneca, Eli Lilly, Merck, Acadia & More - ResearchAndMarkets.com
14 Oct 2022 19:48 GMT
… pharmaceutical companies which are developing targeted novel therapies
According to Alzheimer';s Association, if no novel treatments … Phase III Drugs estimated till 2022 (US$ Mn)
ENA713
Flutemetamol (18F)
LY450139
Dimebon
Aripiprazole/ BMS-337039 …
-
Alzheimers Therapeutic Global Market Report 2022: High Estimates of Future Cases Driving Development & Innovation
11 Oct 2022 10:16 GMT
… pharmaceutical companies which are developing targeted novel therapies
According to Alzheimer';s Association, if no novel treatments … Phase III Drugs estimated till 2022 (US$ Mn)
ENA713
Flutemetamol (18F)
LY450139
Dimebon
Aripiprazole/ BMS-337039 …
-
IIT-Hyderabad researchers make headway in potential treatment of ALS
06 Feb 2020 21:49 GMT
… Dimebon. Dimebon is an antihistamine that was studied for treatment … of neurodegenerative disorders by an American pharmaceutical … promising drug for potential treatment of … Department of Biotechnology, IIT Hyderabad …